Robert W. Downs

8.7k total citations · 2 hit papers
69 papers, 6.6k citations indexed

About

Robert W. Downs is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Robert W. Downs has authored 69 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 21 papers in Oncology and 21 papers in Genetics. Recurrent topics in Robert W. Downs's work include Bone health and osteoporosis research (19 papers), Parathyroid Disorders and Treatments (18 papers) and Bone health and treatments (17 papers). Robert W. Downs is often cited by papers focused on Bone health and osteoporosis research (19 papers), Parathyroid Disorders and Treatments (18 papers) and Bone health and treatments (17 papers). Robert W. Downs collaborates with scholars based in United States, United Kingdom and Belgium. Robert W. Downs's co-authors include Allen M. Spiegel, Arthur C. Santora, Uri Liberman, Jose Adolfo Rodriguez-Portales, Michael A. Levine, Stephen J. Marx, G.D. Aurbach, Norman H. Bell, Henry G. Bone and Murray J. Favus and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Robert W. Downs

68 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

1995 1.8k citations Uri Liberman, Stuart Weiss et al. profile →
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women

2004 982 citations Henry G. Bone, David Hosking et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert W. Downs United States	33	3.5k	2.9k	2.3k	1.2k	1.1k	69	6.6k
Silvano Adami Italy	46	4.9k 1.4×	4.1k 1.4×	2.9k 1.2×	1.3k 1.0×	864 0.8×	142	8.5k
Claude D. Arnaud United States	46	3.8k 1.1×	4.0k 1.4×	3.3k 1.4×	1.3k 1.0×	1.4k 1.3×	95	9.0k
David Karpf United States	24	5.8k 1.7×	4.2k 1.5×	2.5k 1.1×	1.7k 1.4×	761 0.7×	38	7.6k
Sophia Ish‐Shalom Israel	22	3.2k 0.9×	2.5k 0.9×	2.0k 0.9×	864 0.7×	466 0.4×	61	5.2k
P.D. Delmas France	32	2.6k 0.8×	1.7k 0.6×	1.5k 0.6×	852 0.7×	473 0.4×	56	5.5k
Hunter Heath United States	38	1.4k 0.4×	1.7k 0.6×	1.7k 0.7×	741 0.6×	981 0.9×	129	5.9k
Jorma Salmi Finland	27	2.5k 0.7×	2.1k 0.7×	1.7k 0.8×	1.5k 1.2×	712 0.7×	55	5.6k
C Edouard France	30	2.5k 0.7×	2.4k 0.8×	1.6k 0.7×	510 0.4×	367 0.3×	65	4.8k
Gregory Gaich United States	10	2.9k 0.8×	2.4k 0.8×	2.4k 1.1×	818 0.7×	390 0.4×	13	4.7k
M. C. Chapuy France	28	3.2k 0.9×	1.6k 0.6×	1.3k 0.6×	665 0.5×	408 0.4×	51	5.3k

Countries citing papers authored by Robert W. Downs

Since Specialization

Citations

This map shows the geographic impact of Robert W. Downs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. Downs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. Downs more than expected).

Fields of papers citing papers by Robert W. Downs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert W. Downs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. Downs. The network helps show where Robert W. Downs may publish in the future.

Co-authorship network of co-authors of Robert W. Downs

This figure shows the co-authorship network connecting the top 25 collaborators of Robert W. Downs. A scholar is included among the top collaborators of Robert W. Downs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert W. Downs. Robert W. Downs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kornstein, Susan G. & Robert W. Downs. (2020). Introducing Women's Health Reports. Women s Health Reports. 1(1). 1–1. 1 indexed citations

Barrett‐Connor, Elizabeth, Sally Wade, Robert W. Downs, et al.. (2015). Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™. Osteoporosis International. 26(8). 2175–2184. 1 indexed citations

Nestler, John E., et al.. (2012). A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome.. PubMed. 123. 209–19; discussion 219. 15 indexed citations

Downs, Robert W., et al.. (2009). Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass. Osteoporosis International. 21(7). 1215–1226. 7 indexed citations

Johnson, Jason M., James W. Maher, Eric J. DeMaria, et al.. (2006). The Long-term Effects of Gastric Bypass on Vitamin D Metabolism. Annals of Surgery. 243(5). 701–705. 149 indexed citations

Baim, Sanford, Charles R. Wilson, E. Michael Lewiecki, et al.. (2005). Precision Assessment and Radiation Safety for Dual-Energy X-Ray Absorptiometry. Journal of Clinical Densitometry. 8(4). 371–378. 230 indexed citations

Bone, Henry G., David Hosking, Jean‐Pierre Devogelaer, et al.. (2004). Ten Years’ Experience With Alendronate for Osteoporosis in Postmenopausal Women. Obstetrical & Gynecological Survey. 59(8). 597–598. 48 indexed citations

Downs, Robert W., Norman H. Bell, Mark P. Ettinger, et al.. (2000). Comparison of Alendronate and Intranasal Calcitonin for Treatment of Osteoporosis in Postmenopausal Women. Obstetrical & Gynecological Survey. 55(10). 628–629. 13 indexed citations

Downs, Robert W., Norman H. Bell, Mark P. Ettinger, et al.. (2000). Comparison of Alendronate and Intranasal Calcitonin for Treatment of Osteoporosis in Postmenopausal Women*. The Journal of Clinical Endocrinology & Metabolism. 85(5). 1783–1788. 75 indexed citations

10.

Genant, Harry K., Johna Lucas, Stuart Weiss, et al.. (1998). Low-Dose Esterified Estrogen Therapy. Obstetrical & Gynecological Survey. 53(6). 363–364. 2 indexed citations

11.

Liberman, Uri, Stuart Weiss, H. W. Minne, et al.. (1996). Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis. Obstetrical & Gynecological Survey. 51(4). 238–241. 62 indexed citations

12.

McMurtry, Cynthia T., et al.. (1992). Mild Vitamin D Deficiency and Secondary Hyperparathyroidism in Nursing Home Patients Receiving Adequate Dietary Vitamin D. Journal of the American Geriatrics Society. 40(4). 343–347. 42 indexed citations

13.

Godschalk, Michael, James R. Levy, & Robert W. Downs. (1992). Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells. Journal of Bone and Mineral Research. 7(1). 21–27. 68 indexed citations

14.

Doppman, John L., AG Krudy, Stephen J. Marx, et al.. (1983). Aspiration of enlarged parathyroid glands for parathyroid hormone assay.. Radiology. 148(1). 31–35. 77 indexed citations

15.

Downs, Robert W., Michael A. Levine, M. K. Drezner, Warner M. Burch, & Allen M. Spiegel. (1983). Deficient adenylate cyclase regulatory protein in renal membranes from a patient with pseudohypoparathyroidism.. Journal of Clinical Investigation. 71(2). 231–235. 37 indexed citations

16.

Spiegel, Allen M. & Robert W. Downs. (1981). Guanine Nucleotides: Key Regulators of Hormone Receptor-Adenylate Cyclase Interaction. Endocrine Reviews. 2(3). 275–305. 103 indexed citations

17.

Marx, Stephen J., Maurice F. Attie, Michael A. Levine, et al.. (1981). The Hypocalciuric or Benign Variant of Familial Hypercalcemia: Clinical and Biochemical Features in Fifteen Kindreds. Medicine. 60(6). 397–412. 263 indexed citations

18.

Brown, Edward M., Arthur E. Broadus, Murray F. Brennan, et al.. (1979). Direct ComparisonIn VivoandIn Vitroof Suppressibility of Parathyroid Function by Calcium in Primary Hyperparathyroidism*. The Journal of Clinical Endocrinology & Metabolism. 48(4). 604–610. 62 indexed citations

19.

Brown, Edward M., Murray F. Brennan, Arthur E. Broadus, et al.. (1979). Human Parathyroid Autografts: Comparison of Functionin Vivoandin Vitro. The Journal of Clinical Endocrinology & Metabolism. 48(4). 648–654. 21 indexed citations

20.

Shingleton, William W., Hilliard F. Seigler, Lewis H. Stocks, & Robert W. Downs. (1975). Management of recurrent melanoma of the extremity. Cancer. 35(3). 574–579. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact